Literature DB >> 25288160

Embolization treatment of cerebral arteriovenous malformations and amyotrophic lateral sclerosis.

Ourania Katsavarou1, Stefanos Ntampos, Ioannis Sarmas, Nikos Triantafyllou, Sotirios Giannopoulos, Athanassios P Kyritsis.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25288160     DOI: 10.1007/s10072-014-1977-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  3 in total

1.  Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations.

Authors:  Anton Valavanis; Urs Schwarz; Christian R Baumann; Michael Weller; Michael Linnebank
Journal:  J Neurol       Date:  2014-02-08       Impact factor: 4.849

2.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

Review 3.  Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy.

Authors:  Luis B Tovar-Y-Romo; Uri Nimrod Ramírez-Jarquín; Rafael Lazo-Gómez; Ricardo Tapia
Journal:  Front Cell Neurosci       Date:  2014-02-28       Impact factor: 5.505

  3 in total
  1 in total

1.  Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Raph Goldacre; Kevin Talbot; Michael J Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-10       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.